US sPMA for DJO's bone products:
This article was originally published in Clinica
DJO has received FDA approval for a PMA supplement covering several new features built into its combined magnetic field (CMF) OL1000 and SpinaLogic bone growth stimulation product lines. The devices employ the San Diego, California firm's CMF technology, which it claims is the only waveform clinically proven to stimulate bone growth. The technology is indicated for use in aiding the healing of fractures in both long bone and primary lumbar spine applications. The new CMF OL1000 and SpinaLogic products are slated for launch in international markets in September.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.